Standing O is putting out the mat for Dr. Jeffrey Idle, who has joined the staff at Long Island University School of Pharmacy as the new Endowed Professor and Director of the Division of Systems Pharmacology and Pharmacogenomics at The Samuel J. and Joan B. Williamson Institute of the Arnold and Marie Schwartz College of Pharmacy and Health Sciences.
Dr. Idle is one of the world leaders in the fields of metabolomics and pharmacogenetics. Dr. Idle’s work in this field and in pharmacogenetics has been instrumental in moving therapeutics towards more patient-specific tailored treatments in a broad range of medical specialties.
“Dr. Idle’s addition will drive LIU’s evolution into a progressive and leading research institution,” said Dr. John Pezzuto, Dean of LIU Pharmacy and Vice President for LIU Health and Research.”
When completed in early 2018, the new 1,100 square foot lab in the refurbished Pharmacy building will contain state-of-the-art liquid chromatography and gas chromatography-mass spectrometry equipment, together with genomic analysis of DNA, allowing Dr. Idle and his team to advance his vital work at LIU.
“I am excited to join the world-class team at LIU where there is a strong commitment to invest in research,” Dr. Idle said.
LIU School of Pharmacy [75 DeKalb Ave., at Ashland Place in Fort Greene; (718) 488–1004]
©2018 Community News Group
By submitting this comment, you agree to the following terms:
You agree that you, and not BrooklynDaily.com or its affiliates, are fully responsible for the content that you post. You agree not to post any abusive, obscene, vulgar, slanderous, hateful, threatening or sexually-oriented material or any material that may violate applicable law; doing so may lead to the removal of your post and to your being permanently banned from posting to the site. You grant to BrooklynDaily.com the royalty-free, irrevocable, perpetual and fully sublicensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part world-wide and to incorporate it in other works in any form, media or technology now known or later developed.